Abstract
Identifying gene expression changes mediated by signaling pathways is necessary to determine mechanisms that cause phenotypic change. Recent advances in next-generation sequencing and informatic pipelines have streamlined the ability for laboratories to create and analyze transcriptomic data. Here, we describe the preparation of samples and transcriptomic analysis in order to determine gene expression programs regulated by RAS/ERK signaling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Cox AD, Der CJ (2010) Ras history: the saga continues. Small GTPases 1:2–27
Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3:11–22
Fernandez-Medarde A, Santos E (2011) Ras in cancer and developmental diseases. Genes Cancer 2:344–358
Phipps AI, Buchanan DD, Makar KW et al (2013) KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer 108:1757–1764
Meng D, Yuan M, Li X et al (2013) Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis. Lung Cancer 81:1–10
Giehl K (2005) Oncogenic Ras in tumour progression and metastasis. Biol Chem 386: 193–205
Plotnik JP, Budka JA, Ferris MW et al (2014) ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells. Nucleic Acids Res 42:11928–11940
Pollier J, Rombauts S, Goossens A (2013) Analysis of RNA-Seq data with TopHat and Cufflinks for genome-wide expression analysis of jasmonate-treated plants and plant cultures. Methods Mol Biol 1011:305–315
Trapnell C, Roberts A, Goff L et al (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562–578
Reimand J, Arak T, Vilo J (2011) g:Profiler—a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 39(Web Issue):W307–W315
Langmead B (2010) Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics Chapter 11:Unit 11.7
Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111
Reimand J, Kull M, Peterson H et al (2007) g:Profiler—a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res 35(Web Issue): W193–W200
Zeeberg BR, Qin H, Narasimhan S et al (2005) High-throughput GoMiner, an ‘industrial-strength’ integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics 6168
Zhao Y, Adjei AA (2014) The clinical development of MEK inhibitors. Nat Rev Clin Oncol 11:385–400
Samatar AA, Poulikakos PI (2014) Targeting RAS-ERK signalling in cancer: promises and challenges. Nat Rev Drug Discov 13:928–942
Acknowledgement
This work was supported by Research Scholar Award RSG-13-215-01-DMC from the American Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Plotnik, J.P., Hollenhorst, P.C. (2017). Genome-Wide Analysis of RAS/ERK Signaling Targets. In: Jimenez, G. (eds) ERK Signaling. Methods in Molecular Biology, vol 1487. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6424-6_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6424-6_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6422-2
Online ISBN: 978-1-4939-6424-6
eBook Packages: Springer Protocols